Four New Hospitals Begin Certification for SynCardia's Total Artificial Heart
Two Turkish Hospitals and Two U.S. Centers to Complete Phase I in January
TUCSON, Ariz. – Jan. 20, 2011 – On Jan. 20, SynCardia Systems, Inc. announced that four new hospitals, two in Turkey and two in the U.S., have begun certification to implant the SynCardia temporary Total Artificial Heart as a bridge to transplant. The four centers have, or will complete the first of four phases of certification during the month of January.
- Kartal Kosuyolu Yuksek Ihtisas Hastanesi (Istanbul)
Kosuyolu is the largest cardiac center in Turkey and performed 25 heart transplants in 2010. The hospital performs more than 3,500 cardiac surgeries annually. Kosuyolu completed the first phase of certification in Paris on Jan. 14.
- Dr. Siyami Ersek Gogus Kalp Damar Egitim ve Arastirma Hastanesi (Istanbul)
Siyami Ersek is one of the largest cardiac centers in Turkey and performs approximately 3,000 cardiac surgeries annually. There are currently more than 500 people in Turkey in NYHA Class III & IV heart failure who are listed for transplant. The average waiting time for a donor heart in Turkey is approximately 6 months. Siyami Ersek completed the first phase of certification in Paris on Jan. 17.
- Texas Heart Institute at St. Luke’s Episcopal Hospital (Houston, TX)
For 20 consecutive years, the Texas Heart Institute (THI) has been ranked among the top 10 Best Hospitals in Heart and Heart Surgery by U.S. News & World Report. Established in 1982, the transplant program at THI is one of the most experienced, successful programs in the world. Its surgeons have performed more than 1,150 transplant procedures. THI is scheduled to complete Phase I in Tucson, Ariz. on Jan. 24.
- St. Joseph’s Hospital of Atlanta (Atlanta, GA)
Saint Joseph's Heart Transplant Program is one of only three adult heart transplant programs in the Southeast. The hospital has performed more than 400 heart transplants, and its outcomes consistently exceed the national average. St. Joseph’s is scheduled to complete Phase I in Tucson, Ariz. on Jan. 24.
Currently, there are 36 SynCardia Certified Centers around the world including 15 in the U.S. There are an additional 10 U.S. hospitals and 18 international centers currently undergoing certification. SynCardia Certified Centers are located in Germany, Italy, France, Australia, Russia, Austria, Turkey, Sweden, Canada and the U.S.
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the temporary Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, email@example.com, (520) 547-7463